Literature DB >> 33633188

Exploring the conservation of Alzheimer-related pathways between H. sapiens and C. elegans: a network alignment approach.

Avgi E Apostolakou1, Xhuliana K Sula1, Katerina C Nastou1,2, Georgia I Nasi1, Vassiliki A Iconomidou3.   

Abstract

Alzheimer disease (AD) is a neurodegenerative disorder with an -as of yet- unclear etiology and pathogenesis. Research to unveil disease processes underlying AD often relies on the use of neurodegenerative disease model organisms, such as Caenorhabditis elegans. This study sought to identify biological pathways implicated in AD that are conserved in Homo sapiens and C. elegans. Protein-protein interaction networks were assembled for amyloid precursor protein (APP) and Tau in H. sapiens-two proteins whose aggregation is a hallmark in AD-and their orthologs APL-1 and PTL-1 for C. elegans. Global network alignment was used to compare these networks and determine similar, likely conserved, network regions. This comparison revealed that two prominent pathways, the APP-processing and the Tau-phosphorylation pathways, are highly conserved in both organisms. While the majority of interactions between proteins in those pathways are known to be associated with AD in human, they remain unexamined in C. elegans, signifying the need for their further investigation. In this work, we have highlighted conserved interactions related to AD in humans and have identified specific proteins that can act as targets for experimental studies in C. elegans, aiming to uncover the underlying mechanisms of AD.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33633188      PMCID: PMC7907373          DOI: 10.1038/s41598-021-83892-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  63 in total

1.  Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5.

Authors:  K Iijima; K Ando; S Takeda; Y Satoh; T Seki; S Itohara; P Greengard; Y Kirino; A C Nairn; T Suzuki
Journal:  J Neurochem       Date:  2000-09       Impact factor: 5.372

2.  Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase.

Authors:  Masashi Asai; Chinatsu Hattori; Beáta Szabó; Noboru Sasagawa; Kei Maruyama; Sei-ichi Tanuma; Shoichi Ishiura
Journal:  Biochem Biophys Res Commun       Date:  2003-01-31       Impact factor: 3.575

3.  NETAL: a new graph-based method for global alignment of protein-protein interaction networks.

Authors:  Behnam Neyshabur; Ahmadreza Khadem; Somaye Hashemifar; Seyed Shahriar Arab
Journal:  Bioinformatics       Date:  2013-05-21       Impact factor: 6.937

Review 4.  C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease.

Authors:  Christopher D Link
Journal:  Exp Gerontol       Date:  2006-08-23       Impact factor: 4.032

Review 5.  Alzheimer's disease.

Authors:  C A Lane; J Hardy; J M Schott
Journal:  Eur J Neurol       Date:  2017-10-19       Impact factor: 6.089

6.  Conserved pathways within bacteria and yeast as revealed by global protein network alignment.

Authors:  Brian P Kelley; Roded Sharan; Richard M Karp; Taylor Sittler; David E Root; Brent R Stockwell; Trey Ideker
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

7.  A map of the interactome network of the metazoan C. elegans.

Authors:  Siming Li; Christopher M Armstrong; Nicolas Bertin; Hui Ge; Stuart Milstein; Mike Boxem; Pierre-Olivier Vidalain; Jing-Dong J Han; Alban Chesneau; Tong Hao; Debra S Goldberg; Ning Li; Monica Martinez; Jean-François Rual; Philippe Lamesch; Lai Xu; Muneesh Tewari; Sharyl L Wong; Lan V Zhang; Gabriel F Berriz; Laurent Jacotot; Philippe Vaglio; Jérôme Reboul; Tomoko Hirozane-Kishikawa; Qianru Li; Harrison W Gabel; Ahmed Elewa; Bridget Baumgartner; Debra J Rose; Haiyuan Yu; Stephanie Bosak; Reynaldo Sequerra; Andrew Fraser; Susan E Mango; William M Saxton; Susan Strome; Sander Van Den Heuvel; Fabio Piano; Jean Vandenhaute; Claude Sardet; Mark Gerstein; Lynn Doucette-Stamm; Kristin C Gunsalus; J Wade Harper; Michael E Cusick; Frederick P Roth; David E Hill; Marc Vidal
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

Review 8.  Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies.

Authors:  Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

9.  Comparative analysis of protein interaction networks reveals that conserved pathways are susceptible to HIV-1 interception.

Authors:  Xiaoning Qian; Byung-Jun Yoon
Journal:  BMC Bioinformatics       Date:  2011-02-15       Impact factor: 3.169

10.  The post-genomic era of biological network alignment.

Authors:  Fazle E Faisal; Lei Meng; Joseph Crawford; Tijana Milenković
Journal:  EURASIP J Bioinform Syst Biol       Date:  2015-06-04
View more
  4 in total

1.  Neuroprotective Effects of Oligosaccharides in Rehmanniae Radix on Transgenic Caenorhabditis elegans Models for Alzheimer's Disease.

Authors:  Nianxin Kang; Yage Luan; Yu Jiang; Wenhao Cheng; Yongjian Liu; Zhijun Su; Yonggang Liu; Peng Tan
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

Review 2.  Modeling Alzheimer's Disease in Caenorhabditis elegans.

Authors:  Javier Alvarez; Pilar Alvarez-Illera; Jaime Santo-Domingo; Rosalba I Fonteriz; Mayte Montero
Journal:  Biomedicines       Date:  2022-01-26

Review 3.  Structured Long-Chain Omega-3 Fatty Acids for Improvement of Cognitive Function during Aging.

Authors:  Ignasi Mora; Lluís Arola; Antoni Caimari; Xavier Escoté; Francesc Puiggròs
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

4.  An in-silico approach to studying a very rare neurodegenerative disease using a disease with higher prevalence with shared pathways and genes: Cerebral adrenoleukodystrophy and Alzheimer's disease.

Authors:  Yu Jeong Shim; Min Kyoung Shin; Junghyun Jung; Bongseong Koo; Wonhee Jang
Journal:  Front Mol Neurosci       Date:  2022-09-27       Impact factor: 6.261

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.